Quarterly Results
PBH Earnings Forecast
Looking ahead, PBH remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2026/Q3 project quarter revenue of 286.93M and an EPS of 1.18.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2026 have been Revise Upward by 0.21%, while EPS estimates have been Revise Upward by 0.64%. For the upcoming Q3 2026, revenue estimates have been adjusted Revise Downward by -3.04% . These revisions correlate with a 2.20% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in PBH long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
1Y
3Y
5Y
Currency: USD
--
Revenue Estimate-:0
--
EPS Estimate-:0
—
Stock Price0
Earnings Forecast
Revenue
EPS
Currency: USD
Actual
Estimate
Al Analysis
Earnings Surprise Analysis
Revenue
EPS
1Y
3Y
Al Analysis
Earnings Reaction
The chart below shows how PBH performed 10 days before and after its earnings report, based on data from the past quarters. Typically, PBH sees a -0.64% change in stock price 10 days leading up to the earnings, and a -3.02% change 10 days following the report. On the earnings day itself, the stock moves by +1.68%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in SEP/2025, the stock changed -2.30% on the day following the earnings release and then changed by -3.57% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
People Also Watch
Frequently Asked Questions
What were the key highlights of PBH's latest earnings report for FY2026Q2?
PBH reported its FY2026Q2 earnings on 2025-11-06, showcasing a revenue of 274.11M against an estimate of 257.24M, resulting in a 6.56% surprise. The EPS was 1.07, surpassing the expected 0.97 by 10.31% . The stock experienced a 2.56% price change on the earnings day and a 1.25% change over the next five days, reflecting market reactions to the results.
How did PBH's stock price react after the FY2026Q2 earnings release?
Following PBH's FY2026Q2 earnings announcement on 2025-11-06, the stock price moved by 2.56% on the day of the release. Over the subsequent five days, it saw a 1.25% change. Historically, PBH's stock price tends to shift by an average of -0.64% in the 10 days leading up to earnings and -3.02% in the 10 days following, providing insight into potential market.
What are the revenue and EPS estimates for PBH for 2026/Q3?
For 2026/Q3, analysts estimate PBH’s annual revenue to reach 286.93M, while the EPS is projected at 1.18. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 0.21% and EPS estimates Revise Downward by -3.04% over the past three months, indicating analyst expectation in the company’s performance.
How does PBH's stock price correlate with earnings forecast revisions?
The correlation between PBH's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2026 were Revise Upward by 0.21%, while EPS estimates moved Revise Downward by -3.04% . This trend suggests that price dips could present buying opportunities for investors.
What should investors expect from PBH's next earnings report?
Based on historical trends, PBH's stock price typically moves by -0.64% in the 10 days before its earnings and -3.02% in the 10 days after. For the upcoming 2026/Q3 earnings, analysts expect an EPS of 1.18 and revenue of 286.93M.
What is the sentiment in Prestige Consumer Healthcare Inc (PBH) Q2 2026 Earnings Call Summary?
The earnings call summary reflects a mix of positive and negative elements. Basic financial performance is challenged by supply chain issues and declining revenue guidance, while product development and market strategy show potential for recovery and growth. Expenses are manageable with expected cash flow, but the lack of clear guidance and uncertainties in specific areas like Clear Eyes recovery and e-commerce order patterns contribute to a neutral sentiment. Given the market cap, the stock is likely to experience minor fluctuations, resulting in a neutral prediction for the next two weeks.

